For example, the team led by Hai Wang has developed nanoscale mitochondrial inducers (mitoNIDs) that selectively eliminate mitochondria in tumor cells, reduce ROS levels in the TME, and restore the metabolic activity and function of CD8+T cells [89]. The gene discussed is CD8A; the disease is neoplasm.